All In Biotech

Drug Trial Radar · NCT02786901

LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

A Phase 3, Multi-Center, Double-Masked, Vehicle-Controlled, Randomized, Parallel-Group Study to Assess Loteprednol Etabonate Ophthalmic Gel, (BID and TID) Versus Vehicle Gel

Last checked: Nov 19, 2026Latest source record: Jan 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

600

Actual

Start

Jun 2016

Primary completion

Jun 13, 2017

Study completion Jul 1, 2017

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedIndustry
Sponsor type
Industry
First posted
Jun 1, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Loteprednol Etabonate Ophthalmic Gel, (BID and TID) versus Vehicle Group for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery.

Conditions

  • Cataract
  • Pain
  • Ocular Inflammation

Interventions

  • Loteprednol Etabonate Ophthalmic Gel dosed TIDDrug

    Gel

  • Loteprednol Etabonate Ophthalmic Gel dosed BIDDrug

    Gel

  • Vehicle GelDrug

    Gel

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Complete Resolution of Anterior Chamber (AC) Cells at Visit 5 (Postoperative Day 8)Time frame: 8 days
  2. Number of Participants With Complete Resolution of Ocular Pain in Study Eye at Visit 5 (Postoperative Day 8)Time frame: 8 days

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Valeant Site 01

    Phoenix, Arizona

  • Valeant Site 03

    Oceanside, California

  • Valeant Site 05

    Miami, Florida

  • Valeant Site 04

    Quincy, Massachusetts

  • Valeant Site 06

    Kansas City, Missouri

  • Valeant Site 02

    St Louis, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.